Guess what? The fresh blueberries you buy at the store are not wild blueberries. My fascination with wild blueberries began as a child when I stumbled upon them while wandering the woods. Unlike their cultivated cousins, true wild blueberries grow naturally without human intervention, thriving in the harsh climates of northern Maine and parts of
Elie Mystal The court has given itself nearly unlimited power over the administrative state, putting everything from environmental protections to workers’ rights at risk. The post We Just Witnessed the Biggest Supreme Court Power Grab Since 1803 appeared first on The Nation…
Abortion-rights supporters in several states have used the citizen initiative process to protect access to the procedure. But voters in half the states don’t have that right…
Want to know why human-generated content gets 5.4 times more traffic than AI-generated material? Learn the game-changing strategies that can make your AI content feel more authentic and engaging…
FCC Chairwoman Jessica Rosenworcel has drafted a series of letters to nine major telecom companies, including AT&T and Comcast, to ask if they’re actually doing anything about AI political robocalls. AI-generated voices are getting pretty good at mimicking humans and we’ve already seen this technology in action…
Despite their size, wetlands smaller than 8 ha perform valuable services, including biodiversity protection, floodwater storage, water quality maintenance, and climate regulation (1, 2). However, human activities and climate change have driven widespread loss and degradation of small wetlands, causing substantial declines in ecological functions (3…
NASA’s 2024 Human Lander Challenge (HuLC) Forum brought 12 university teams from across the United States to Huntsville, Alabama, near the agency’s Marshall Space Flight Center, to showcase their innovative concepts for addressing the complex issue of managing lunar dust. The 12 finalists, selected in March 2024…
At its June 27 meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorizations for four cancer therapies. Balversa The CHMP endorsed the approval of Balversa (erdafitinib, Janssen-Cilag International N.V.), intended for the treatment of urothelial carcinoma…